‘Any medicine is at risk’: Biotech execs condemn judicial overturning of abortion pill approval

More than 200 biotech executives, investors and scientists have signed an open letter condemning a Texas judge’s decision to overturn the FDA approval of mifepristone, an abortion pill that’s been widely used for more than two decades.